HOXA-AS2 and non-small cell lung carcinoma: Additionally, HOXA-AS2 is implicated in the development and progression of various other cancers, including CC [171], papillary thyroid cancer[172], type I endometrial carcinoma [173], NPC [174], osteosarcoma [175], NSCLC [176], bladder cancer (BCa) [177], and thoracic aortic aneurysm [178].